Sorry, I think that's wishful thinking. I would just be thrilled to hear the CHF meeting actually getting scheduled. Given how they responded to our GVHD resubmission, I have little hope for a near term AA for CHF. What I expect is a trial with 1 year end point on ejection fraction, the results could then lead to AA or possibly full approval. We need a partner to fund; perhaps with some clear guidance from FDA we will get one. We are approaching 2 years since FDA requested that additional data from the CHF trial. Too many people dying from CHF - it is a travesty that this has been sitting on hold for so long.
Ann: Update on BLA for Graft Versus Host Disease, page-968
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.045(4.37%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $1.995M | 1.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 34862 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 78733 | 5 |
View Market Depth
| Last trade - 10.59am 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |